Articles tagged with Muscle Atrophy
A team of researchers from the University of Iowa has identified Gadd45a as a key culprit causing muscle atrophy, reprogramming hundreds of genes that ultimately lead to muscle deterioration. The protein affects muscles in two main ways: instructing cells to produce fewer proteins and causing existing proteins to break down.
Researchers found that acupuncture can reverse decreases in muscle mass and mRNA expression levels of muscle-specific atrophic genes. The study holds promise for improving mobility through muscle rejuvenation in the elderly and medical patients.
Researchers have discovered a potential treatment for muscle wasting disorders using a compound found in apple peel called ursolic acid. The study found that ursolic acid promoted muscle growth and reduced muscle atrophy in mice, while also lowering body fat, blood sugar levels, cholesterol, and triglycerides.
Researchers discovered a link between antioxidant enzyme deficiency and impaired mitochondrial function, leading to muscle cell death. The findings offer new insights into sarcopenia and neuromuscular diseases, potentially paving the way for future muscle-preserving therapies.
A study published in the FASEB Journal shows that free radicals cause mitochondrial damage in muscle cells, resulting in accelerated age-related muscle loss. Researchers hope to develop new treatments to slow or limit this process.
A recent study by Dr. Basil Petrof reveals that the CFTR gene is involved in calcium regulation in skeletal muscles, contributing to muscle atrophy and weakness in cystic fibrosis patients. The research also suggests that controlling inflammation and infection may be key to treating CF-related muscle atrophy.
Researchers discovered a potential new treatment for muscle atrophy, a debilitating condition characterized by loss of muscle mass and function. Des-acyl ghrelin, an appetite-stimulating hormone, shows anti-atrophic activity on skeletal muscle in mice with muscular atrophy.
Researchers found that enzyme MuRF1 selectively degrades thick filaments in muscle, while thin filaments are bypassed. This ordered process enables the muscle to maintain its structure and function during atrophy.
Researchers are sending worms to the International Space Station to study muscle atrophy in zero gravity. The goal is to understand why astronauts experience dramatic muscle loss and potentially develop new treatments for muscle wasting diseases.
Researchers found a significant decline in muscle fibers in the diaphragm after just 18 hours of mechanical ventilation. The study's results suggest that intervening in the molecular pathway responsible for muscle wasting could lead to the development of a new pharmacological approach to safely wean patients off ventilators.
Researchers found a chemical switch in the body that allows muscle atrophy to occur and how to turn it off. They developed methods to block the protein's ability to cause atrophy using gene therapy and drug treatment.
Research at Cold Spring Harbor Laboratory explores novel approaches to preventing muscle atrophy by optimizing exercise and nutritional interventions. The study highlights the importance of combining resistance training with specific nutrient profiles to maintain muscle mass and function.
A recent study published in the Journal of Clinical Investigation found a significant link between heart failure and weight loss. The researchers discovered that angiotensin II inhibits IGF-1 signaling in skeletal muscle, leading to muscle loss, which is reversed by IGF-1 expression.
Researchers discovered a gene, atrogin-1, that plays a critical role in muscle atrophy. This protein triggers excessive protein breakdown, leading to muscle loss in various conditions, including space-related muscle wasting.